Literature DB >> 2110905

In vitro activity of cefpirome (HR810) against Enterococcus species.

P F Wheat, R C Spencer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2110905     DOI： 10.1007/bf01963849

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Rapid antibiotic susceptibility tests on Enterobacteriaceae by ATP bioluminescence.

Authors:  P F Wheat; J G Hastings; R C Spencer
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

2.  In vitro activity of HR 810, a new cephalosporin.

Authors:  M A Bertram; D A Bruckner; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

3.  Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.

Authors:  N Klesel; M Limbert; E Schrinner; K Seeger; G Seibert; I Winkler
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

4.  Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

5.  In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.

Authors:  P H Chandrasekar; S Price; D P Levine
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

6.  A novel luminometer for rapid antimicrobial susceptibility tests on gram-positive cocci by ATP bioluminescence.

Authors:  P F Wheat; R C Spencer; J G Hastings
Journal:  J Med Microbiol       Date:  1989-08       Impact factor: 2.472
  6 in total
  1 in total

Review 1.  Cefpirome clinical pharmacokinetics.

Authors:  L C Strenkoski; D E Nix
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.